What is Lenvenib 4mg (LENVATINIB)?
Multi-kinase inhibitor for differentiated thyroid cancer, hepatocellular carcinoma (HCC), endometrial carcinoma (with pembrolizumab), and renal cell carcinoma.
How it Works
Inhibits VEGFR1-3, FGFR1-4, PDGFRalpha, KIT, and RET kinases — broadly blocks tumor angiogenesis and proliferative signaling.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Shelf Life | 2–3 years (properly stored) |
| Storage | Room temperature (15–25°C), cool dry place |
| Brand | Pharma |
| Pack Size | 105 tablets |
| Dose per Tablet | 4MG |
Frequently Asked Questions
🧪 Peptide Research Tools: Use QSC's free peptide calculators — reconstitution, BAC water, dosing, half-life, and mixing charts.
🌍 Domestic shipping: 🇺🇸 USA 5–7 days
🌏 International shipping: 7–14 days